Work

Abstract CT268: Preliminary results from a first-in-human study of IK-595, an oral MEK/RAF molecular glue, in patients with RAS- or RAF-altered advanced solid tumors

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct268

Authors: Anthony W. Tolcher, Nehal J. Lakhani, Meredith McKean, Babar Bashir, Jason T. Henry, Andrae L. Vandross, Alexander I. Spira, Jennifer B. Valerin, Trupti Lingaraj, Katherine Kim, Wilmin Bartolini, Marissa Timothy, Katherine Kacena, David Damphousse, Jeffrey Ecsedy, Caroline Germa, Jason J. Luke

Institutions: Sarah Cannon, Thomas Jefferson University, Sidney Kimmel Cancer Center, HealthONE, University of California, Irvine, UPMC Health System, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409821591

Cites:

Cited by: 2

Related to: 10